Treatment of Low-Blast Count AML using Hypomethylating Agents

In 2002, the WHO classification reduced the proportion of blasts in the bone marrow (BM) necessary for the diagnosis of acute myeloid leukemia (AML) from 30% to 20%, eliminating the RAEB-t subtype of myelodysplastic syndromes (MDS). However, this AML subtype, defined as low-blast count AML (LBC-AML,...

詳細記述

保存先:
書誌詳細
出版年:Mediterr J Hematol Infect Dis
主要な著者: De Bellis, Eleonora, Fianchi, Luana, Buccisano, Francesco, Criscuolo, Marianna, Maurillo, Luca, Cicconi, Laura, Brescini, Mattia, Del Principe, Maria Ilaria, Di Veroli, Ambra, Venditti, Adriano, Amadori, Sergio, Arcese, William, Lo-Coco, Francesco, Voso, Maria Teresa
フォーマット: Artigo
言語:Inglês
出版事項: Università Cattolica del Sacro Cuore 2017
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499495/
https://ncbi.nlm.nih.gov/pubmed/28698788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.045
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料